Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension

نویسندگان

  • Shusuke Yagi
  • Akira Takashima
  • Minoru Mitsugi
  • Toshihiro Wada
  • Junko Hotchi
  • Ken-ichi Aihara
  • Tomoya Hara
  • Masayoshi Ishida
  • Daiju Fukuda
  • Takayuki Ise
  • Koji Yamaguchi
  • Takeshi Tobiume
  • Takashi Iwase
  • Hirotsugu Yamada
  • Takeshi Soeki
  • Tetsuzo Wakatsuki
  • Michio Shimabukuro
  • Masashi Akaike
  • Masataka Sata
چکیده

BACKGROUND Hypertension is one of the major risk factors for cardiovascular and cerebrovascular disease and mortality. Patients who receive insufficient doses of antihypertensive agents or who are poorly adherent to multidrug treatment regimens often fail to achieve adequate blood pressure (BP) control. The aim of this study was to determine the efficacy of an angiotensin II receptor blocker (ARB) and calcium channel blocker (CCB) combination tablet containing a regular dose of irbesartan (100 mg) and a high dose of amlodipine (10 mg) with regard to lowering BP and other risk factors for cardiovascular disease. METHODS We retrospectively evaluated data from 68 patients with essential hypertension whose treatment regimen was changed either from combination treatment with an independent ARB and a low-dose or regular-dose CCB or from a combination tablet of ARB and a low-dose or regular-dose CCB to a combination tablet containing amlodipine 10 mg and irbesartan 100 mg, because of incomplete BP control. Previous treatments did not include irbesartan as the ARB. RESULTS The combination tablet decreased systolic and diastolic BP. In addition, it significantly decreased serum uric acid, low-density lipoprotein cholesterol, and increased high-density lipoprotein cholesterol levels, independent of the BP-lowering effect. Treatment with the combination tablet did not affect serum triglycerides, plasma glucose, glycated hemoglobin, serum potassium or creatinine levels, or the urinary albumin excretion rate. CONCLUSION The combination tablet containing amlodipine 10 mg and irbesartan 100 mg had a greater BP-lowering effect than an ARB and a low-dose or regular-dose CCB. In addition, the combination tablet had more favorable effects on serum uric acid, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol levels in patients with hypertension.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Irbesartan: a review of its use alone and in combination with hydrochlorothiazide

10.1586/14750708.3.6.733 © 2 Blood pressure is one of the most important and frequent risk factors for cardiovascular disease morbidity and mortality; however, it is largely uncontrolled in the population. Inhibition of the renin–angiotensin–aldosterone system provides beneficial effects in the hypertensive population. Association of low-dosed diuretics in drug combinations with renin–angiotens...

متن کامل

Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine

BACKGROUND Guidelines for the management of hypertension recommend the use of drugs with different mechanisms of action in antihypertensive regimens that include single-pill fixed-dose combinations of medications. There is some controversy regarding which single-pill fixed-dose combinations of angiotensin II type 1 receptor blockers (ARBs) and calcium channel blockers (CCBs) are effective at re...

متن کامل

Can large-scale trials or meta-analyses demonstrate blood pressure--independent effect of angiotensin receptor blockers?

Response to Can Large-Scale Trials or Meta-Analyses Demonstrate Blood Pressure–Independent Effect of Angiotensin Receptor Blockers? Minami et al1 put forward an interesting hypothesis on the existence of nonresponders to angiotensin receptor blockers (ARBs). However, this hypothesis does not refute that large trials or their meta-analyses2 can demonstrate blood pressure–independent influence of...

متن کامل

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?

Accepted: 30 April 2013; published online: 28 May 2013 Citation: J Drug Assess 2013; 2:67–71 In a recently published paper in the Journal of Drug Assessment, Axthelm et al. reported on the effectiveness of single-pill combination (SPC) aliskiren 300 mg/ amlodipine 10 mg in high-risk subgroups of hypertensive patients with uncontrolled blood pressure (BP). Briefly, 4-week’s treatment with SPC al...

متن کامل

Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.

Current guidelines from the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommend first-line treatment with a thiazide diuretic but do not provide specific guidance for obese patients. The renin system is activated in obesity-associated arterial hypertension. Therefore, we tested the hypothesis that the oral direct renin inhibitor aliskire...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 11  شماره 

صفحات  -

تاریخ انتشار 2015